Christine Gomes, BS

Tergus Pharma, LLC

Poster(s):

• (T1530-11-72) Evaluation of Supported-Liquid Extraction Technique and Matrix Effect in LCMS-MS Method Development of a Model Hydrophobic Drug
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET

• (T1030-11-73) Industry Understanding for Overcoming Challenges to Demonstrate IVPT Sensitivity by Dose Amount and Dose Duration Modulation as per FDA Draft Guidance for Topical Drug Products
  Tuesday, October 24, 2023

  10:30 AM – 11:30 AM ET

• (M0930-11-76) The Impact of Relative Humidity on In Vitro Permeation Test Method Performance Indicators, J_max, T_max and Amount Permeated for Molecule, TER-003
  Monday, October 23, 2023

  9:30 AM – 10:30 AM ET